SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-12-057104
Filing Date
2012-10-22
Accepted
2012-10-22 10:52:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS v326237_424b3.htm 424B3 180109
  Complete submission text file 0001144204-12-057104.txt   181204
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-184173 | Film No.: 121153968
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences